Comparing yoga and physiotherapy for sarcoidosis treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effects of yoga and conventional physiotherapy programs on patients diagnosed with sarcoidosis, particularly focusing on those with pulmonary involvement and fatigue symptoms. The trial aims to assess improvements in lung capacity, inspiratory muscle strength, and overall quality of life through these non-pharmacological interventions. Participants will be divided into two groups, one receiving traditional physiotherapy and the other engaging in a structured yoga program. The study seeks to fill a gap in the literature regarding non-drug treatments for sarcoidosis, which is often associated with significant emotional and physical challenges.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Being diagnosed with Sarcoidosis by a physician (Stage II-III-IV)
* Pulmonary involvement
* Having fatigue symptoms (FAS ≥22 points)
* No immunosuppressive drug use for the last 1 year
* No antidepressant use for the last 6 months

Exclusion Criteria:

* Presence of cognitive impairment that prevents communication
* Anemia
* Uveitis
* Diabetes
* Pregnancy
* Major cardiovascular diseases
* Fractures
* Osteoporosis
* Those who have a neurological or orthopedic disease that will affect the treatment
* Those who are in the exacerbation period of the disease
* Tumor

Where it's running

• Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital
  Istanbul, Maltepe, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Şeyda YILDIZ, PhD(c), PT
• Email: yildizseydaa@gmail.com
• Phone: +905378484687

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

  A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

  Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

• Two prednisolone tapering plans for people with stable sarcoidosis

  The team will try two different prednisolone tapering plans to see if people with stable sarcoidosis taking 5–10 mg/day can safely cut their dose by at least half.

  Recruiting Royal Brompton & Harefield NHS Foundation Trust · London · NCT07498842

• Adding Street Racket to outpatient pulmonary rehabilitation

  This project will test whether Street Racket, a simple group racket game, can be added to outpatient pulmonary rehabilitation for adults with chronic lung disease to make sessions more acceptable and engaging.

  Recruiting University of Zurich · Zurich and 1 other locations · NCT07430943

• Health Haven: Comprehensive maintenance program for COPD in Lleida (NAPOLEON)

  This 12-month randomized trial will test whether a supervised, multidimensional maintenance pulmonary rehabilitation program helps adults with moderate to severe COPD keep symptom relief and quality-of-life gains after their initial rehab.

  Recruiting at 2 sites Institut de Recerca Biomèdica de Lleida · Lleida, Catalonia and 1 other locations · NCT07394712

• Immune cells in lung disease and how they could guide immunotherapy

  This project sees if immune cell profiling from blood can explain why people with lung cancer, sarcoidosis, or COPD respond differently to immunotherapy or develop chronic lung inflammation.

  Recruiting Université Catholique de Louvain · Brussels · NCT07384897

• Inspiratory muscle training added to pulmonary rehabilitation for people with RA-related interstitial lung disease

  This project will test whether adding inspiratory muscle training to standard pulmonary rehabilitation helps people with rheumatoid arthritis-associated interstitial lung disease breathe easier, walk farther, gain muscle strength, feel better psychologically, and change levels of certain long noncoding RNAs.

  Recruiting Saglik Bilimleri Universitesi · Istanbul, Turkey · NCT07320846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.